effective cases are not well understood. A low-dose macrolide therapy is effective in patients with diffuse panbronchiolitis where neutrophilic inflammation is existed in both upper and lower airways. Furthermore, macrolides also appear to be effective in neutrophilic rhinosinusitis. In this study, we investigated the effect of low-dose macrolide therapy in uncontrolled asthmatic patients who have also been diagnosed with chronic neutrophilic rhinosinusitis.
Results: Six cases (3 males, median age 49) started receiving macrolides. The sputum production was observed in all cases. 3 cases showed both high IgE level and positive for environmental inhalation antigen. The reduction of ICS doses was successfully achieved by the lowdose macrolide therapy in 4 out of 6 cases. In addition, macrolides reduced the number of exacerbation, and significantly improved ACT score (17.8 ! 24.2, P < 0.05) compared to values before the administration. The concentration of FeNO was varied among the patients and that data was not improved by the treatment with macrolides.
Conclusion:
These results indicate that coexistence of neutrophilic rhinosinusitis is associated with poor asthma control and that low-dose macrolide therapy is useful for controlling these patients. Our findings suggest that the type of inflammatory cells involved in the coexisting rhinosinusitis may be a predictive marker of the efficacy of low-dose macrolide therapy in patients with severe asthma. Global Initiative for Asthma (GINA) 2017 recommended not to withdraw inhaled corticosteroid (ICS) in the adult asthmatics, but evidence remains unclear and the long-term use of ICS may induce side-effects. We analyzed patients with asthma who discontinued ICS after usage for 6 months or more, by using data of National Health Insurance Sharing Service (NHISS), which reflects real-world practice.
Methods: Among data extracted from NHISS between 2010 and 2011, the asthma was defined with the diagnosis of asthma and ICS medication possession rate > 50% in a year. The people with the diagnosis of COPD and long term systemic steroid users were excluded. The Asthma patients are divided into two groups, patients who continued ICS (ICS continuation group) and patients who stopped ICS more than 6 months (ICS withdrawal group). Moderate exacerbation was defined with the prescription of systemic steroid for 3 days or more and severe exacerbation was defined with hospitalization for asthma.
Results: A total of 1,160 asthma patients were identified as above definition. Among them, 278 stopped ICS for more than 6 months. In this ICS withdrawal group, 27 (9.7%) patients experienced moderate exacerbation. 25 (9.0%) patients had severe exacerbation. In ICS continuation group, 94 (10.7%) patients experienced moderate exacerbation, and 73 (8.3%) patients experienced severe exacerbation. The rate and the frequency of exacerbation were not different between two groups (P = 0.65 and P = 0.22, moderate, P = 0.71 and P = 0.94, severe). Background and Aims: The population of Japan is declining after the peak in 2008. Also, the ratio occupied by 75 years or older is 13.8%. By the highest aging population and low birthrate, it is predicted that its ratio will rise to 20.2% in 2040. In a super-aged society, the increase of number of elderly asthma is predicted.
We investigated the actual situation about elderly asthma for making a future strategy to them.
Methods:
We intended the patients with asthma who visited our outpatient clinic regularly from January to March 2017 (n = 976, female = 566, mean age: 63.8 years) retrospectively. The number of patients divided by age group were under 65 years (n = 402), 65-74 years (associate elderly, n = 302), 75-89 years (elderly, n = 265), 90 years or older (super elderly, n = 7), respectively. We analyzed patient's lung function, forced oscillation technique, FeNO, asthma control, blood eosinophils, serum IgE level. We compared some variables with the data of the patients with asthma in our outpatient clinic investigated in 2008.
Results: The percentage of 75 years or older was 27.9%. Because the same ratio was 21.6% in 2008, the aging of patients found to advance. Small airway damage became strong with aging, but the degree of damage became milder than in 2008. With aging, the ratio of poor control increased. The blood eosinophil count surpasses 5% and FeNO showed around 35 ppb in 75 years or older patients.
Conclusion:
It was suggested the treatment for eosinophilic airway inflammation was necessary for acquiring improvement of elderly patient's control, because its inflammation was equivalent to non-elderly patients. Therefore, we have to consideration about how appropriate antiinflammatory therapy is provided in an individual elderly patient with asthma. Background and Aims: The asthmatic patients in Thailand had hospitalization and emergency room visit from asthma exacerbation about 15 % and 21 % respectively which affect to patient outcome and quality of life so health provider should be known the situation of service in patient with asthma exacerbation for asthma exacerbation management effectively. To study the situation of service in patient with asthma exacerbation focus on rate of exacerbation, problem and cause of asthma exacerbation.
